Article Details
Retrieved on: 2018-01-23 09:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Vanguard Group</b> Inc. lifted its holdings in CytRx by 53.9% in the second quarter. <b>Vanguard Group</b> Inc. now owns 4,823,123 shares of the biotechnology company's stock valued at $3,024,000 after buying an additional 1,689,874 shares during the period. Institutional investors own 44.82% of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here